To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RALYTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
557 representative clones for gene RALY back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG481648 choriocarcinoma, placenta .a 1 to 796 1 to 806   tiling clone,   806/983
(81 %)
20 diff
(98.0 %id)
BP265632 thyroid .a 75 to 656 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BE263295 brain, neuroblastoma .a 106 to 962 31 to 870       840/881
(95 %)
32 diff
(96.4 %id)
BE879428 large cell carcinoma, undifferentiated, lung .a 111 to 899 1 to 782       782/997
(78 %)
21 diff
(97.9 %id)
BF312801 brain, neuroblastoma .a 114 to 784 1 to 675       675/1099
(61 %)
19 diff
(98.3 %id)
TI_57202648   .a 161 to 975 64 to 880       817/880
(92 %)
9 diff
(99.0 %id)
BI823469 pooled brain, lung, testis .a 170 to 975 1 to 809       809/809
(100 %)
4 diff
(99.6 %id)
DC332737 hippocampus .a 222 to 776 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BP272972   .a 222 to 781 1 to 560       560/565
(99 %)
7 diff
(98.8 %id)
BI906098 leukocyte .a 233 to 990 1 to 760       760/761
(99 %)
17 diff
(97.8 %id)
TI_57231557   .a 233 to 990 33 to 792       760/793
(95 %)
22 diff
(97.3 %id)
BF976082 B-cells, primary B-cells from tonsils (cell line) .a 236 to 985 1 to 758       758/915
(82 %)
18 diff
(98.1 %id)
BU521021 leiomyosarcoma, uterus .a 238 to 935 1 to 711       711/804
(88 %)
19 diff
(97.7 %id)
CX165204 human embryonic stem cells differentiated toan early endodermal cell type .a 239 to 1026 1 to 788       788/788
(100 %)
0 diff
(100 %id)
BG281802 melanotic melanoma, skin .a 365 to 1116 1 to 756       756/914
(82 %)
12 diff
(98.7 %id)
BF027114 melanotic melanoma, skin .a 371 to 1160 32 to 828       797/847
(94 %)
22 diff
(97.5 %id)
CN364398 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 377 to 1090 10 to 723       714/723
(98 %)
7 diff
(99.1 %id)
BM458604 lymph, lymphoma, cell line .a 378 to 1195 1 to 821   tiling clone,   821/1130
(72 %)
12 diff
(99.0 %id)
CA406746 adipose .a 380 to 924 1 to 542       542/542
(100 %)
3 diff
(99.5 %id)
BF026440 melanotic melanoma, skin .a 385 to 1162 1 to 787       787/1011
(77 %)
26 diff
(97.5 %id)
BE385356 melanotic melanoma, skin .a 387 to 893 1 to 506       506/506
(100 %)
1 diff
(99.9 %id)
DC298979   .a 392 to 1152 1 to 764       764/764
(100 %)
8 diff
(99.0 %id)
TI_57183936   .a 983 to 1683 29 to 761   tiling clone,   698/862
(80 %)
41 diff
(95.3 %id)
BI767846 pooled lung and spleen .a 990 to 1683 1 to 726   tiling clone,   691/827
(83 %)
38 diff
(95.5 %id)
BG340373 leiomyosarcoma cell line, uterus .b 1 to 786 1 to 781   tiling clone,   781/781
(100 %)
28 diff
(96.5 %id)
BI823524 pooled brain, lung, testis .b 192 to 917 1 to 726   tiling clone,   726/726
(100 %)
14 diff
(98.1 %id)
TI_57202704   .b 192 to 917 60 to 785       726/785
(92 %)
17 diff
(97.9 %id)
DC395869 testis .b 232 to 744 1 to 513       513/513
(100 %)
0 diff
(100 %id)
TI_57148995   .b 244 to 955 25 to 735       711/735
(96 %)
7 diff
(99.1 %id)
TI_57175787   .b 244 to 1080 63 to 902       840/903
(93 %)
20 diff
(97.8 %id)
BI829056 brain, medulla .b 249 to 1080 1 to 835       835/836
(99 %)
14 diff
(98.4 %id)
BI764375 pooled colon, kidney, stomach .b 249 to 955 1 to 706       706/706
(100 %)
2 diff
(99.8 %id)
BQ890293 brain, neuroblastoma, cell line .b 251 to 1149 1 to 910       910/939
(96 %)
14 diff
(98.6 %id)
BE869081 adenocarcinoma, colon .b 273 to 917 1 to 649       649/1203
(53 %)
24 diff
(98.1 %id)
DC398891 testis .b 281 to 854 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
CR997308 T-Lymphocytes .b 315 to 1097 1 to 785   tiling clone,   785/785
(100 %)
2 diff
(99.8 %id)
BQ887612 eye, retinoblastoma .b 417 to 1213 1 to 803       803/930
(86 %)
20 diff
(97.9 %id)
BF309279 muscle, rhabdomyosarcoma .b 600 to 1325 1 to 725   tiling clone,   725/1039
(69 %)
11 diff
(99.0 %id)
BE299905 muscle, rhabdomyosarcoma .b 620 to 1350 1 to 730   tiling clone, fully sequenced,   730/730
(100 %)
6 diff
(99.2 %id)
BE295405 muscle, rhabdomyosarcoma .b 620 to 1311 1 to 688   tiling clone,   688/774
(88 %)
13 diff
(98.4 %id)
BE299524 muscle, rhabdomyosarcoma .b 1289 to 1788 598 to 91   tiling clone, fully sequenced,   508/598
(84 %)
12 diff
(98.0 %id)
CR622300 Neuroblastoma Cot 25-normalized .c 1 to 1431 3 to 1433 exact     1433/1433
(100 %)
0 diff
(100 %id)
CR623780 Neuroblastoma Cot 25-normalized .c 1 to 1432 3 to 1434 exact tiling clone,   1434/1434
(100 %)
0 diff
(100 %id)
AL524053 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1 to 451 3 to 454   fully sequenced,   454/454
(100 %)
7 diff
(98.5 %id)
AL524071 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1 to 706 3 to 708   fully sequenced,   708/708
(100 %)
1 diff
(99.9 %id)
BX417093 placenta .c 1 to 1088 2 to 1088       1088/1110
(98 %)
31 diff
(97.3 %id)
AA281678 germinal center B cell .c 1 to 351 1 to 350       350/350
(100 %)
6 diff
(98.3 %id)
DA970126 stomach .c 1 to 570 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
CN364416 embryonic stem cells, DMSO-treated H9 cellline .c 2 to 386 1 to 385       385/385
(100 %)
0 diff
(100 %id)
BG774772 choriocarcinoma, placenta .c 7 to 728 1 to 723       689/726
(94 %)
13 diff
(98.3 %id)
BQ672537 epidermoid carcinoma, cell line, salivary gland .c 16 to 631 9 to 626       618/977
(63 %)
16 diff
(98.4 %id)
BE385840 melanotic melanoma, skin .c 19 to 710 1 to 696       662/715
(92 %)
17 diff
(97.7 %id)
DB459360 testis .c 20 to 502 1 to 483       483/483
(100 %)
3 diff
(99.4 %id)
BE389853 endometrium, adenocarcinoma cell line, uterus .c 22 to 606 1 to 586       586/586
(100 %)
6 diff
(99.0 %id)
DB055216 testis .c 25 to 580 2 to 559   capped   558/558
(100 %)
3 diff
(99.5 %id)
BM462634 melanotic melanoma, skin .c 28 to 832 1 to 824       824/965
(85 %)
21 diff
(97.9 %id)
DB448086 testis .c 29 to 462 1 to 434       434/434
(100 %)
0 diff
(100 %id)
DA686738   .c 32 to 554 2 to 525   capped   524/524
(100 %)
2 diff
(99.7 %id)
DB191385 lung, tumor tissue .c 33 to 574 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
BF306510 muscle, rhabdomyosarcoma .c 37 to 680 1 to 644       644/644
(100 %)
0 diff
(100 %id)
BG826371 muscle, rhabdomyosarcoma .c 37 to 839 1 to 804       804/901
(89 %)
6 diff
(99.4 %id)
AL045133 testis .c 38 to 115 1 to 78       78/78
(100 %)
0 diff
(100 %id)
CV810486 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 40 to 847 1 to 811       811/874
(92 %)
25 diff
(97.2 %id)
AU099241   .c 41 to 340 1 to 300       300/300
(100 %)
0 diff
(100 %id)
AU104824   .c 41 to 90 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BQ435124 melanotic melanoma, skin .c 42 to 797 5 to 768       764/876
(87 %)
19 diff
(97.9 %id)
CN364400 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 50 to 539 1 to 490       490/490
(100 %)
0 diff
(100 %id)
BX105074 liver and spleen .c 51 to 777 1 to 727       727/727
(100 %)
1 diff
(99.9 %id)
BE295095 muscle, rhabdomyosarcoma .c 57 to 710 1 to 651       651/652
(99 %)
7 diff
(99.0 %id)
BE269686 Burkitt lymphoma, lymph .c 57 to 716 1 to 660       660/660
(100 %)
0 diff
(100 %id)
CT002377 T-Lymphocytes .c 63 to 955 1 to 893       893/920
(97 %)
5 diff
(99.5 %id)
DB455094 testis .c 74 to 571 1 to 498       498/499
(99 %)
1 diff
(99.8 %id)
BM764055 myeloma .c 82 to 428 1 to 347       347/347
(100 %)
2 diff
(99.5 %id)
CD624127   .c 83 to 530 468 to 21       448/472
(94 %)
0 diff
(100 %id)
CN364412 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 119 to 383 1 to 265       265/265
(100 %)
0 diff
(100 %id)
BY995576   .c 119 to 808 21 to 710       690/710
(97 %)
5 diff
(99.3 %id)
R73202 breast .c 136 to 419 1 to 284       284/284
(100 %)
3 diff
(99.0 %id)
DA893240 skeletal muscle .c 141 to 682 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
BG764194 melanotic melanoma, high MDR (cell line), skin .c 143 to 1037 1 to 895       895/990
(90 %)
18 diff
(98.2 %id)
DA728290   .c 151 to 847 2 to 697   capped   696/710
(98 %)
5 diff
(99.3 %id)
DB501525 hypothalamus .c 152 to 627 1 to 475       475/480
(98 %)
7 diff
(98.6 %id)
BG387549 embryonal carcinoma, cell line, testis .c 161 to 847 1 to 686       686/1083
(63 %)
9 diff
(99.2 %id)
BE272194 adenocarcinoma cell line, ovary .c 165 to 767 1 to 603       603/603
(100 %)
0 diff
(100 %id)
CN364407 embryonic stem cells, DMSO-treated H9 cellline .c 178 to 517 1 to 341       341/341
(100 %)
2 diff
(99.5 %id)
BQ068547 brain, neuroblastoma, cell line .c 182 to 1015 1 to 839       839/991
(84 %)
15 diff
(98.5 %id)
BQ887975 brain, neuroblastoma, cell line .c 182 to 1023 1 to 848       848/919
(92 %)
8 diff
(99.2 %id)
CV813522 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 190 to 984 1 to 799       799/800
(99 %)
19 diff
(97.7 %id)
TI_45133401   .c 190 to 977 59 to 850       790/793
(99 %)
11 diff
(98.7 %id)
TI_45133669   .c 190 to 974 61 to 849       789/789
(100 %)
22 diff
(97.3 %id)
BM830595 Ascites, stomach .c 191 to 656 1 to 466       466/466
(100 %)
0 diff
(100 %id)
BU521415 leiomyosarcoma, uterus .c 199 to 1033 12 to 853       842/876
(96 %)
14 diff
(98.5 %id)
BF882333 lung_tumor .c 214 to 799 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BE886583 leiomyosarcoma, uterus .c 221 to 956 1 to 743       743/1123
(66 %)
13 diff
(98.9 %id)
BG678495 skin, squamous cell carcinoma .c 233 to 1029 1 to 800       800/863
(92 %)
20 diff
(97.7 %id)
BE304342 adenocarcinoma cell line, colon .c 241 to 918 1 to 675       675/680
(99 %)
8 diff
(98.9 %id)
BU845517 ovary, teratocarcinoma, cell line .c 257 to 1026 1 to 772       772/798
(96 %)
5 diff
(99.4 %id)
BU931028 ovary, teratocarcinoma, cell line .c 257 to 995 1 to 739       739/927
(79 %)
5 diff
(99.5 %id)
BM700479 eye, lens .c 257 to 816 1 to 560       560/560
(100 %)
0 diff
(100 %id)
BM920159 pooled pancreas and spleen .c 260 to 1021 5 to 770       766/779
(98 %)
4 diff
(99.5 %id)
BU146730 brain, neuroblastoma, cell line .c 264 to 1022 1 to 766       766/770
(99 %)
12 diff
(98.5 %id)
CX755078 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 266 to 977 1 to 709       709/862
(82 %)
6 diff
(99.4 %id)
F01280 leg muscle, skeletal muscle .c 267 to 592 1 to 328       328/336
(97 %)
6 diff
(98.3 %id)
BF310604 brain, neuroblastoma .c 267 to 962 1 to 697       697/949
(73 %)
27 diff
(97.2 %id)
DN989610 brain, whole brain .c 280 to 627 8 to 355       348/355
(98 %)
0 diff
(100 %id)
BQ675422 epidermoid carcinoma, cell line, salivary gland .c 302 to 1012 1 to 711       711/931
(76 %)
9 diff
(99.1 %id)
TI_57170566   .c 305 to 1124 31 to 849       819/850
(96 %)
15 diff
(98.3 %id)
BI825342 brain, medulla .c 306 to 1124 1 to 818       818/819
(99 %)
6 diff
(99.3 %id)
R95986 pineal gland .c 310 to 409 1 to 100       100/100
(100 %)
0 diff
(100 %id)
BQ669480 epidermoid carcinoma, cell line, salivary gland .c 313 to 1028 1 to 717       717/957
(74 %)
8 diff
(99.2 %id)
BQ669435 epidermoid carcinoma, cell line, salivary gland .c 313 to 1008 1 to 703       703/867
(81 %)
8 diff
(99.1 %id)
BE741293 adenocarcinoma cell line, ovary .c 319 to 1082 1 to 763       763/763
(100 %)
6 diff
(99.3 %id)
BQ893932 epidermoid carcinoma, cell line, salivary gland .c 320 to 1041 1 to 726       726/730
(99 %)
9 diff
(98.8 %id)
BQ674837 epidermoid carcinoma, cell line, salivary gland .c 320 to 1017 1 to 699       699/913
(76 %)
7 diff
(99.3 %id)
BQ669698 epidermoid carcinoma, cell line, salivary gland .c 320 to 1021 1 to 705       705/923
(76 %)
11 diff
(98.9 %id)
BM794514 Ascites, stomach .c 332 to 964 1 to 633       633/633
(100 %)
0 diff
(100 %id)
CN364411 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 341 to 480 1 to 140       140/140
(100 %)
1 diff
(99.3 %id)
BM739799 Ascites, stomach .c 345 to 890 1 to 546       546/546
(100 %)
0 diff
(100 %id)
TI_57193283   .c 346 to 1079 54 to 791       738/961
(76 %)
14 diff
(98.6 %id)
BM855471 Ascites, stomach .c 347 to 943 1 to 597       597/597
(100 %)
0 diff
(100 %id)
BF882690 lung_tumor .c 363 to 760 398 to 1     Submitted on the opposite strand 398/398
(100 %)
0 diff
(100 %id)
BF882704 lung_tumor .c 363 to 760 398 to 1     Submitted on the opposite strand 398/398
(100 %)
0 diff
(100 %id)
BE890981 melanotic melanoma, skin .c 364 to 1065 1 to 704       704/766
(91 %)
20 diff
(97.4 %id)
TI_154179968   .c 373 to 1130 78 to 827       750/889
(84 %)
21 diff
(97.7 %id)
CA397482 eye, RPE/choroid .c 379 to 942 1 to 564       564/564
(100 %)
0 diff
(100 %id)
BG957208 colon .c 387 to 847 475 to 16       462/503
(91 %)
0 diff
(100 %id)
CX787983 human embryonic stem cells .c 387 to 1231 1 to 845       845/845
(100 %)
4 diff
(99.6 %id)
BE770035 prostate_tumor .c 388 to 653 407 to 142       266/407
(65 %)
0 diff
(100 %id)
BE797408 lung, small cell carcinoma .c 392 to 1009 1 to 618       618/618
(100 %)
0 diff
(100 %id)
TI_154172196   .c 397 to 1001 80 to 683       604/606
(99 %)
6 diff
(99.1 %id)
AL138372 melanoma (MeWo cell line) .c 407 to 924 1 to 518       518/518
(100 %)
0 diff
(100 %id)
AW391889 stomach .c 415 to 958 544 to 1       544/544
(100 %)
1 diff
(99.9 %id)
BQ890348 eye, normal pigmented retinal epithelium .c 420 to 1045 1 to 626       626/631
(99 %)
3 diff
(99.6 %id)
AL562307 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 421 to 1406 1008 to 27   fully sequenced,   982/1008
(97 %)
20 diff
(98.1 %id)
CR985203 T-Lymphocytes .c 434 to 1038 1 to 605       605/605
(100 %)
0 diff
(100 %id)
BQ337847 nervous_normal .c 454 to 626 181 to 6       176/195
(90 %)
6 diff
(97.0 %id)
CB114801 Liver .c 467 to 944 1 to 478       478/478
(100 %)
0 diff
(100 %id)
TI_57167471   .c 484 to 1038 123 to 701       526/701
(75 %)
17 diff
(97.6 %id)
BG120387 adenocarcinoma, cell line, Liver .c 551 to 1323 1 to 770       770/771
(99 %)
17 diff
(97.8 %id)
BM762778 lymph node, stomach .c 561 to 1024 1 to 464       464/464
(100 %)
0 diff
(100 %id)
BM764272 lymph node, stomach .c 561 to 928 1 to 368       368/368
(100 %)
0 diff
(100 %id)
BM840916 lymph node, stomach .c 561 to 1012 1 to 452       452/452
(100 %)
0 diff
(100 %id)
BM843085 lymph node, stomach .c 561 to 1037 1 to 477       477/477
(100 %)
0 diff
(100 %id)
BM851348 lymph node, stomach .c 561 to 965 1 to 405       405/405
(100 %)
0 diff
(100 %id)
BM844866 lymph node, stomach .c 561 to 1012 1 to 452       452/452
(100 %)
0 diff
(100 %id)
BM781482 lymph node, stomach .c 561 to 941 1 to 381       381/381
(100 %)
0 diff
(100 %id)
BM781484 lymph node, stomach .c 561 to 1024 1 to 464       464/464
(100 %)
0 diff
(100 %id)
BM781495 lymph node, stomach .c 561 to 1024 1 to 464       464/464
(100 %)
0 diff
(100 %id)
BM781498 lymph node, stomach .c 561 to 1024 1 to 464       464/464
(100 %)
0 diff
(100 %id)
BX353252 Neuroblastoma Cot 25-normalized .c 562 to 1410 880 to 1       494/880
(56 %)
25 diff
(97.2 %id)
BE747096 adenocarcinoma cell line, ovary .c 577 to 1204 1 to 628       628/628
(100 %)
0 diff
(100 %id)
BM738717 Ascites, stomach .c 642 to 783 1 to 142       142/142
(100 %)
0 diff
(100 %id)
AL524070 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 645 to 1431 790 to 1   fully sequenced,   790/790
(100 %)
18 diff
(97.8 %id)
AA634978 lung, lung carcinoma .c 681 to 971 1 to 290       290/290
(100 %)
3 diff
(99.0 %id)
BM466316 eye, retinoblastoma .c 710 to 929 1 to 220       220/220
(100 %)
0 diff
(100 %id)
AA335403 epididymis .c 761 to 903 1 to 143       143/143
(100 %)
1 diff
(99.4 %id)
BQ650151 hepatocellular carcinoma, cell line, Liver .c 766 to 1045 1 to 280       280/284
(98 %)
1 diff
(99.7 %id)
EC473408 Prostate .c 772 to 857 10 to 95       86/95
(90 %)
6 diff
(93.7 %id)
N28329 melanocyte .c 772 to 988 1 to 217       217/217
(100 %)
2 diff
(99.1 %id)
AI660586 colon, colonic mucosa from 3 patients with Crohn'sdisease .c 772 to 1447 676 to 1       676/679
(99 %)
8 diff
(98.9 %id)
CN364421 embryonic stem cells, DMSO-treated H9 cellline .c 774 to 1041 1 to 269       269/269
(100 %)
3 diff
(98.9 %id)
BM826062 Ascites, stomach .c 801 to 1145 1 to 348       348/348
(100 %)
2 diff
(99.5 %id)
AA349061 adrenal gland .c 809 to 1098 1 to 289       289/289
(100 %)
4 diff
(98.7 %id)
BF848854 lung_normal .c 849 to 998 185 to 34     Submitted on the opposite strand 152/185
(82 %)
2 diff
(99.0 %id)
CB164775 Liver .c 855 to 1042 1 to 188       188/188
(100 %)
0 diff
(100 %id)
CB162697 Liver .c 855 to 1042 1 to 188       188/188
(100 %)
0 diff
(100 %id)
CB164681 Liver .c 855 to 1033 1 to 179       179/179
(100 %)
0 diff
(100 %id)
AA683470 uterus .c 944 to 1442 502 to 1   tiling clone,   502/502
(100 %)
12 diff
(97.7 %id)
BM729153 eye, fetal eye .c 1017 to 1175 170 to 12     Submitted on the opposite strand 159/171
(92 %)
0 diff
(100 %id)
AA143315   .c 1028 to 1379 353 to 1       353/353
(100 %)
6 diff
(98.4 %id)
AI803526   .c 1073 to 1214 142 to 1       142/148
(95 %)
5 diff
(96.7 %id)
AA827223 germinal center B cell .c 1104 to 1212 111 to 3       109/121
(90 %)
3 diff
(97.6 %id)
AA013068 eye, retina .c 1126 to 1206 1 to 81       81/88
(92 %)
3 diff
(96.6 %id)
AA292970 ovarian tumor, ovary .c 1138 to 1216 1 to 79       79/79
(100 %)
4 diff
(95.0 %id)
H52643 ovarian tumor, ovary .c 1141 to 1212 1 to 72       72/76
(94 %)
1 diff
(98.7 %id)
AW303050 invasive adenocarcinoma, lung .c 1142 to 1380 42 to 280     Submitted on the opposite strand 239/280
(85 %)
6 diff
(97.9 %id)
BM810267 amelanotic melanoma, cell line, skin .d 1 to 795 27 to 828   tiling clone,   802/1170
(68 %)
38 diff
(96.8 %id)
BM915468 amelanotic melanoma, cell line, skin .d 2 to 794 1 to 798       798/1086
(73 %)
20 diff
(98.2 %id)
BQ652977 hepatocellular carcinoma, cell line, Liver .d 6 to 676 1 to 683       683/988
(69 %)
19 diff
(98.1 %id)
BF205121 muscle, rhabdomyosarcoma .d 12 to 666 1 to 656       656/656
(100 %)
6 diff
(99.1 %id)
BQ882393 brain, neuroblastoma, cell line .d 12 to 862 1 to 856       856/908
(94 %)
20 diff
(97.8 %id)
BQ883196 brain, neuroblastoma, cell line .d 12 to 789 1 to 784       784/909
(86 %)
22 diff
(97.6 %id)
AW410734 muscle, rhabdomyosarcoma .d 13 to 471 20 to 478       459/488
(94 %)
6 diff
(98.8 %id)
CR613485 HeLa cells Cot 25-normalized .d 14 to 1804 1 to 1791 exact tiling clone,   1791/1791
(100 %)
0 diff
(100 %id)
BX384191   .d 14 to 926 1 to 910   fully sequenced,   910/910
(100 %)
5 diff
(99.5 %id)
TI_57189690   .d 16 to 654 48 to 686       639/639
(100 %)
7 diff
(99.0 %id)
BI860549 breast, mammary adenocarcinoma, cell line .d 18 to 654 1 to 637       637/637
(100 %)
7 diff
(99.0 %id)
BE898064 melanotic melanoma, skin .d 37 to 692 1 to 657       657/972
(67 %)
8 diff
(99.2 %id)
CR604151 Placenta Cot 25-normalized .d 42 to 1785 1 to 1744 exact     1744/1744
(100 %)
0 diff
(100 %id)
BX334845 Placenta Cot 25-normalized .d 42 to 918 1 to 875   fully sequenced,   875/875
(100 %)
2 diff
(99.8 %id)
DC366564   .d 45 to 605 1 to 561       561/561
(100 %)
0 diff
(100 %id)
CR599150 neuroblastoma .d 48 to 1816 1 to 1769 exact     1769/1769
(100 %)
0 diff
(100 %id)
AL518149 brain, neuroblastoma, neuroblastoma cells .d 48 to 936 1 to 887   fully sequenced,   887/887
(100 %)
5 diff
(99.5 %id)
BQ217676 large cell carcinoma, lung .d 54 to 821 1 to 769       769/932
(82 %)
12 diff
(98.8 %id)
CR609461 HeLa cells Cot 25-normalized .d 73 to 1785 1 to 1713 exact     1713/1713
(100 %)
0 diff
(100 %id)
BX362946   .d 73 to 927 1 to 854   fully sequenced,   854/854
(100 %)
5 diff
(99.5 %id)
BG386709 adenocarcinoma cell line, colon .d 74 to 811 1 to 736       736/736
(100 %)
4 diff
(99.5 %id)
BG831910 epithelioid carcinoma cell line, Pancreas .d 77 to 951 1 to 883       879/883
(99 %)
19 diff
(97.9 %id)
CR625534 fetal brain .d 79 to 1784 1 to 1706 exact     1706/1706
(100 %)
0 diff
(100 %id)
AL536547 brain, fetal brain .d 79 to 926 1 to 844   fully sequenced,   844/844
(100 %)
5 diff
(99.5 %id)
BQ225234 leiomyosarcoma, uterus .d 82 to 814 1 to 734       734/1030
(71 %)
11 diff
(99.0 %id)
DC424537 ovary, tumor tissue .d 83 to 788 1 to 705       705/706
(99 %)
6 diff
(99.2 %id)
BG748727 eye, normal pigmented retinal epithelium .d 85 to 1058 1 to 964       964/983
(98 %)
20 diff
(98.0 %id)
BQ933457 epidermoid carcinoma, cell line, lung .d 91 to 891 1 to 802       802/969
(82 %)
17 diff
(98.3 %id)
DR763059 embryonic stem .d 98 to 911 1 to 814       814/814
(100 %)
0 diff
(100 %id)
BE313821 brain, neuroblastoma .d 99 to 737 1 to 637       637/641
(99 %)
14 diff
(97.9 %id)
BQ425756 melanotic melanoma, skin .d 100 to 789 1 to 691       691/919
(75 %)
13 diff
(98.6 %id)
BM561262 amelanotic melanoma, cell line, skin .d 104 to 804 1 to 715       715/1157
(61 %)
28 diff
(97.6 %id)
DB502279 hypothalamus .d 106 to 580 1 to 475       475/475
(100 %)
1 diff
(99.8 %id)
BE207289 lung, small cell carcinoma .d 107 to 687 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
CR603257 Neuroblastoma Cot 10-normalized .d 110 to 1803 1 to 1694 exact     1694/1694
(100 %)
0 diff
(100 %id)
BG333621 melanotic melanoma, skin .d 110 to 891 1 to 790       788/1016
(77 %)
21 diff
(98.0 %id)
CR612346 neuroblastoma .d 112 to 1805 1 to 1694 exact     1694/1694
(100 %)
0 diff
(100 %id)
AL517133 brain, neuroblastoma, neuroblastoma cells .d 112 to 926 1 to 813   fully sequenced,   813/813
(100 %)
5 diff
(99.4 %id)
BG436841 large cell carcinoma, lung .d 114 to 737 1 to 624       624/624
(100 %)
0 diff
(100 %id)
BE796966 lung, small cell carcinoma .d 116 to 866 1 to 751       751/1036
(72 %)
5 diff
(99.6 %id)
BG473682 eye, retinoblastoma .d 117 to 849 1 to 732       732/736
(99 %)
5 diff
(99.4 %id)
BQ929467 leiomyosarcoma, uterus .d 118 to 1019 1 to 905       905/918
(98 %)
12 diff
(98.7 %id)
BU556522 ovary, teratocarcinoma, cell line .d 118 to 821 33 to 738       706/1041
(67 %)
25 diff
(97.6 %id)
BI260953 cervical carcinoma cell line, cervix .d 120 to 851 1 to 734       734/734
(100 %)
2 diff
(99.8 %id)
CR613686 HeLa cells Cot 25-normalized .d 121 to 1787 1 to 1667 exact     1667/1667
(100 %)
0 diff
(100 %id)
BX363253   .d 121 to 1102 1 to 976       976/976
(100 %)
5 diff
(99.5 %id)
CR982814 T-Lymphocytes .d 121 to 422 1 to 302       302/302
(100 %)
0 diff
(100 %id)
CN364404 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 127 to 527 1 to 403       403/403
(100 %)
2 diff
(99.6 %id)
BU856314 ovary, teratocarcinoma, cell line .d 135 to 785 1 to 651       651/1016
(64 %)
5 diff
(99.6 %id)
BI115552 muscle, rhabdomyosarcoma .d 155 to 784 1 to 634       634/634
(100 %)
6 diff
(99.1 %id)
DC397948 testis .d 190 to 760 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DC360977   .d 197 to 769 1 to 575       575/575
(100 %)
4 diff
(99.4 %id)
DC387791 small intestine .d 197 to 659 1 to 463       463/463
(100 %)
0 diff
(100 %id)
DC421748 uterus .d 197 to 740 1 to 545       545/545
(100 %)
1 diff
(99.9 %id)
CR596751 Neuroblastoma Cot 25-normalized .d 199 to 1791 1 to 1593 exact     1593/1593
(100 %)
0 diff
(100 %id)
BG674522 skin .d 207 to 1103 1 to 905       905/908
(99 %)
29 diff
(96.9 %id)
BI161141 epithelioid carcinoma cell line, Pancreas .d 207 to 1002 1 to 794       794/797
(99 %)
6 diff
(99.3 %id)
BM042256 melanotic melanoma, cell line, skin .d 207 to 814 1 to 606       606/606
(100 %)
1 diff
(99.9 %id)
BQ677028 melanotic melanoma, cell line, skin .d 211 to 1024 1 to 824       824/924
(89 %)
20 diff
(97.9 %id)
CR595464 fetal liver .d 212 to 1788 1 to 1577 exact     1577/1577
(100 %)
0 diff
(100 %id)
AL531230 brain, fetal liver, Liver, neuroblastoma cells .d 212 to 966 1 to 753   fully sequenced,   753/753
(100 %)
1 diff
(99.9 %id)
BG770291 melanotic melanoma, high MDR (cell line), skin .d 213 to 965 1 to 758       758/760
(99 %)
8 diff
(99.0 %id)
BQ279229 adenocarcinoma, cell line, breast .d 214 to 821 1 to 608       608/1134
(53 %)
9 diff
(99.3 %id)
BX333656 Neuroblastoma Cot 25-normalized .d 218 to 966 20 to 767   fully sequenced,   748/767
(97 %)
6 diff
(99.3 %id)
DC364949 esophagus .d 221 to 783 1 to 563       563/563
(100 %)
0 diff
(100 %id)
DC340851 thalamus .d 224 to 819 1 to 596       596/596
(100 %)
2 diff
(99.7 %id)
CR614904 fetal brain .d 232 to 1805 1 to 1574 exact     1574/1574
(100 %)
0 diff
(100 %id)
AL535080 brain, fetal brain .d 232 to 966 1 to 733   fully sequenced,   733/733
(100 %)
2 diff
(99.8 %id)
BC103753 Peripheral Nervous System, dorsal rootganglion .d 240 to 1833 1 to 1597 G231S S239G G240S S244G G245S ... AAA   1597/1597
(100 %)
3 diff
(99.9 %id)
DC306842 cerebellum .d 243 to 811 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
DC354773 lung .d 245 to 722 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
DC297522   .d 246 to 740 1 to 496       496/497
(99 %)
3 diff
(99.4 %id)
DC297957   .d 246 to 722 1 to 477       477/477
(100 %)
0 diff
(100 %id)
DC302440 cerebellum .d 246 to 843 1 to 599       599/599
(100 %)
2 diff
(99.7 %id)
DC306010 cerebellum .d 246 to 805 1 to 561       561/561
(100 %)
1 diff
(99.9 %id)
DC311223 alzheimer cortex .d 246 to 795 1 to 550       550/550
(100 %)
0 diff
(100 %id)
DC312561 alzheimer cortex .d 246 to 799 1 to 554       554/554
(100 %)
0 diff
(100 %id)
DC312809 alzheimer cortex .d 246 to 830 1 to 585       585/585
(100 %)
0 diff
(100 %id)
DC320087 brain .d 246 to 806 1 to 561       561/561
(100 %)
0 diff
(100 %id)
DC322057 brain .d 246 to 791 1 to 546       546/546
(100 %)
1 diff
(99.9 %id)
DC339406 subthalamic nucleus .d 246 to 799 1 to 556       556/556
(100 %)
2 diff
(99.7 %id)
DC365232   .d 246 to 827 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
DC365446 ovary .d 246 to 807 1 to 562       562/562
(100 %)
0 diff
(100 %id)
DC376704 brain .d 246 to 792 1 to 548       548/548
(100 %)
2 diff
(99.7 %id)
BM829196 Ascites, stomach .d 246 to 719 1 to 474       474/474
(100 %)
0 diff
(100 %id)
DC388556 small intestine .d 246 to 740 1 to 495       495/495
(100 %)
0 diff
(100 %id)
DC399117 testis .d 246 to 814 1 to 571       571/572
(99 %)
2 diff
(99.7 %id)
DC410652 thymus .d 246 to 839 1 to 594       594/594
(100 %)
4 diff
(99.4 %id)
DC422843 uterus .d 246 to 789 1 to 544       544/544
(100 %)
0 diff
(100 %id)
CB130324 Liver .d 248 to 692 1 to 445       445/445
(100 %)
0 diff
(100 %id)
DC393098 breast, tumor tissue .d 248 to 789 1 to 542       542/542
(100 %)
0 diff
(100 %id)
DC307657 cerebellum .d 249 to 792 1 to 544       544/544
(100 %)
1 diff
(99.9 %id)
DC312520 alzheimer cortex .d 249 to 877 1 to 629       629/629
(100 %)
1 diff
(99.9 %id)
DB476797 hippocampus .d 249 to 752 1 to 504       504/504
(100 %)
4 diff
(99.3 %id)
DB493325 hypothalamus .d 249 to 743 1 to 495       495/495
(100 %)
3 diff
(99.4 %id)
DB496583 hypothalamus .d 249 to 743 1 to 495       495/495
(100 %)
3 diff
(99.4 %id)
DB503756 hypothalamus .d 249 to 724 1 to 476       476/476
(100 %)
2 diff
(99.6 %id)
DC365324 ovary .d 249 to 799 1 to 552       552/552
(100 %)
1 diff
(99.9 %id)
BM754531 stomach .d 249 to 716 1 to 470       470/470
(100 %)
2 diff
(99.6 %id)
BM841934 myeloma .d 249 to 763 1 to 515       515/515
(100 %)
1 diff
(99.9 %id)
DC405672 thymus .d 249 to 691 1 to 444       444/444
(100 %)
1 diff
(99.8 %id)
DC413384 lung, tumor tissue .d 249 to 802 1 to 555       555/555
(100 %)
1 diff
(99.9 %id)
DC423684 uterus .d 249 to 846 1 to 598       598/598
(100 %)
0 diff
(100 %id)
CN364417 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 250 to 800 8 to 558       551/558
(98 %)
6 diff
(99.0 %id)
TI_57233686   .d 253 to 965 25 to 737       713/737
(96 %)
8 diff
(99.0 %id)
TI_57152335   .d 254 to 1005 27 to 779       753/779
(96 %)
6 diff
(99.3 %id)
TI_154188792   .d 254 to 1113 120 to 970       851/941
(90 %)
19 diff
(98.0 %id)
BX458990 placenta .d 255 to 1216 1 to 955       955/1078
(88 %)
16 diff
(98.6 %id)
BM545007 ovary (pool of 3) .d 256 to 1214 21 to 983       963/1129
(85 %)
26 diff
(97.7 %id)
BM924827 pooled colon, kidney, stomach .d 256 to 1214 1 to 966       966/1100
(87 %)
29 diff
(97.4 %id)
CX164943 human embryonic stem cells differentiated toan early endodermal cell type .d 256 to 1097 1 to 842       842/842
(100 %)
0 diff
(100 %id)
TI_57164338   .d 256 to 1102 32 to 881       850/936
(90 %)
24 diff
(97.5 %id)
BQ213742 embryonal carcinoma, cell line, testis .d 257 to 895 1 to 641       641/1079
(59 %)
8 diff
(99.3 %id)
CN364420 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 258 to 980 1 to 723       723/723
(100 %)
0 diff
(100 %id)
CR597090 HeLa cells Cot 25-normalized .d 258 to 1805 1 to 1548 exact     1548/1548
(100 %)
0 diff
(100 %id)
CR615132 Placenta Cot 25-normalized .d 258 to 1810 1 to 1553 exact     1553/1553
(100 %)
0 diff
(100 %id)
BX384430   .d 258 to 966 1 to 707   fully sequenced,   707/707
(100 %)
3 diff
(99.6 %id)
BX346284   .d 258 to 936 1 to 679   fully sequenced,   679/679
(100 %)
6 diff
(99.2 %id)
BI915647 brain .d 258 to 800 1 to 543       543/545
(99 %)
2 diff
(99.7 %id)
TI_57167110   .d 258 to 1084 24 to 849       826/849
(97 %)
11 diff
(98.8 %id)
CN364403 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 259 to 803 8 to 552       545/552
(98 %)
6 diff
(99.0 %id)
BI835490 pooled pancreas and spleen .d 259 to 703 1 to 445       445/445
(100 %)
2 diff
(99.6 %id)
BX357777 Placenta Cot 25-normalized .d 260 to 1098 1 to 839       839/924
(90 %)
4 diff
(99.6 %id)
BQ053178 blood, natural killer cells, cell line .d 260 to 1101 1 to 846       846/1093
(77 %)
14 diff
(98.8 %id)
CR983524 T-Lymphocytes .d 260 to 966 1 to 707       707/707
(100 %)
0 diff
(100 %id)
AF148457 testis .d 261 to 1833 1 to 1573 exact AAA   1573/1573
(100 %)
0 diff
(100 %id)
DR155365 human embryonic stem cells differentiated toan early endodermal cell type .d 261 to 1002 1 to 742       742/742
(100 %)
0 diff
(100 %id)
NM_016732.1   .d 261 to 1833 1 to 1573 exact RefSeq, AAA   1573/1573
(100 %)
0 diff
(100 %id)
BI834952 pooled pancreas and spleen .d 263 to 1084 1 to 821       821/821
(100 %)
5 diff
(99.4 %id)
CX872744 embryonic stem .d 263 to 1023 1 to 761       761/761
(100 %)
0 diff
(100 %id)
CD300336 testis .d 263 to 1070 1 to 815       815/898
(90 %)
9 diff
(99.0 %id)
AL518058 brain, neuroblastoma, neuroblastoma cells .d 264 to 804 1 to 540       540/540
(100 %)
6 diff
(98.9 %id)
TI_154187570   .d 268 to 1067 121 to 909       789/943
(83 %)
16 diff
(98.4 %id)
TI_154140373   .d 270 to 989 86 to 803       718/719
(99 %)
14 diff
(98.1 %id)
BI917162 brain .d 272 to 1093 1 to 821       821/821
(100 %)
7 diff
(99.2 %id)
TI_57242454   .d 272 to 1093 46 to 866       821/866
(94 %)
13 diff
(98.5 %id)
CR596021 Placenta Cot 25-normalized .d 288 to 1820 1 to 1533 exact     1533/1533
(100 %)
0 diff
(100 %id)
CR615528 Placenta Cot 25-normalized .d 295 to 1810 1 to 1516 exact     1516/1516
(100 %)
0 diff
(100 %id)
CR600862 Placenta Cot 25-normalized .d 298 to 1776 1 to 1479 exact     1479/1479
(100 %)
0 diff
(100 %id)
BX360041 Placenta Cot 25-normalized .d 298 to 966 1 to 674   fully sequenced,   674/674
(100 %)
11 diff
(98.4 %id)
N42660 melanocyte .d 300 to 544 1 to 242       242/242
(100 %)
2 diff
(99.2 %id)
AK222915 Kidney .d 301 to 1833 1 to 1536 G231S S239G G240S S244G G245S ... AAA   1536/1536
(100 %)
2 diff
(99.9 %id)
CR606402 Placenta Cot 25-normalized .d 305 to 1805 1 to 1501 exact     1501/1501
(100 %)
0 diff
(100 %id)
BX381369 Placenta Cot 25-normalized .d 305 to 1082 1 to 777   fully sequenced,   777/777
(100 %)
3 diff
(99.7 %id)
BC105018 Brain, cerebral cortex, PCR rescued clones .d 392 to 1597 1 to 1206 exact     1206/1206
(100 %)
0 diff
(100 %id)
AK291079   .d 410 to 1833 1 to 1427 G231S S239G G240S S244G G245S ...     1427/1427
(100 %)
2 diff
(99.9 %id)
AW245783 lung, small cell carcinoma .d 421 to 1021 10 to 610       601/610
(98 %)
6 diff
(99.1 %id)
TI_1241110653   .d 465 to 1597 1169 to 55     Submitted on the opposite strand 1054/1232
(85 %)
17 diff
(98.7 %id)
CR611602 Neuroblastoma Cot 25-normalized .d 466 to 1806 1 to 1341 exact     1341/1341
(100 %)
0 diff
(100 %id)
BM697465 eye, fetal eyes .d 479 to 1081 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BM718310 eye, fetal eye .d 486 to 1133 1 to 648   fully sequenced,   648/648
(100 %)
1 diff
(99.9 %id)
BM712411 eye, lens .d 658 to 1186 1 to 529       529/529
(100 %)
0 diff
(100 %id)
BM710908 eye, fetal eyes .d 677 to 1187 1 to 511       511/511
(100 %)
0 diff
(100 %id)
BG819837 anaplastic oligodendroglioma with 1p/19qloss, brain .d 695 to 1568 1 to 874       874/881
(99 %)
31 diff
(96.5 %id)
TI_57173479   .d 722 to 1528 31 to 835       805/835
(96 %)
18 diff
(97.9 %id)
BM723071 eye, fetal eye .d 800 to 1133 1 to 334   fully sequenced,   334/334
(100 %)
0 diff
(100 %id)
BX363252   .d 814 to 1776 976 to 12       965/1086
(88 %)
2 diff
(99.9 %id)
AL518057 brain, neuroblastoma, neuroblastoma cells .d 815 to 1806 988 to 1       988/988
(100 %)
27 diff
(97.3 %id)
BX334844 Placenta Cot 25-normalized .d 857 to 1783 932 to 2   fully sequenced,   931/932
(99 %)
4 diff
(99.6 %id)
CR626461 Neuroblastoma Cot 25-normalized .d 885 to 1835 1 to 951   tiling clone,   951/951
(100 %)
0 diff
(100 %id)
BX324510 Neuroblastoma Cot 25-normalized .d 885 to 1828 1 to 945   fully sequenced,   945/945
(100 %)
19 diff
(98.0 %id)
AL517132 brain, neuroblastoma, neuroblastoma cells .d 896 to 1805 914 to 1   fully sequenced,   914/914
(100 %)
8 diff
(99.2 %id)
AL566380 brain, fetal brain .d 896 to 1784 892 to 1   fully sequenced,   892/892
(100 %)
3 diff
(99.7 %id)
BX384190   .d 896 to 1802 916 to 2   fully sequenced,   915/916
(99 %)
9 diff
(99.1 %id)
BX362945   .d 897 to 1785 892 to 1   fully sequenced,   892/892
(100 %)
5 diff
(99.5 %id)
AL518148 brain, neuroblastoma, neuroblastoma cells .d 905 to 1816 915 to 1   fully sequenced,   915/915
(100 %)
11 diff
(98.8 %id)
BX333655 Neuroblastoma Cot 25-normalized .d 905 to 1791 890 to 1   fully sequenced,   890/890
(100 %)
5 diff
(99.5 %id)
AL535079 brain, fetal brain .d 905 to 1805 904 to 1   fully sequenced,   904/904
(100 %)
1 diff
(99.9 %id)
BX360040 Placenta Cot 25-normalized .d 905 to 1776 878 to 1   fully sequenced,   878/878
(100 %)
7 diff
(99.3 %id)
BX384429   .d 905 to 1805 905 to 1   fully sequenced,   905/905
(100 %)
3 diff
(99.7 %id)
BX346283   .d 905 to 1794 904 to 17   fully sequenced,   888/904
(98 %)
7 diff
(99.3 %id)
AL531229 brain, fetal liver, Liver, neuroblastoma cells .d 905 to 1788 887 to 1   fully sequenced,   887/887
(100 %)
6 diff
(99.4 %id)
TI_1241112219   .d 907 to 1597 1 to 692       692/1262
(54 %)
5 diff
(99.7 %id)
BM708147 eye, RPE and Choroid .d 917 to 1266 1 to 350   fully sequenced,   350/350
(100 %)
2 diff
(99.5 %id)
BX381368 Placenta Cot 25-normalized .d 1052 to 1805 758 to 1   fully sequenced,   758/758
(100 %)
13 diff
(98.3 %id)
BM677518 eye, fetal eye .d 1072 to 1833 784 to 19   fully sequenced, AAA   766/766
(100 %)
9 diff
(98.9 %id)
BU741902 eye, fetal eye .d 1077 to 1833 776 to 19   fully sequenced, AAA   758/758
(100 %)
2 diff
(99.8 %id)
BX336627 Placenta Cot 25-normalized .d 1097 to 1785 693 to 1       693/842
(82 %)
7 diff
(99.2 %id)
BM825769 Ascites, stomach .d 1106 to 1502 1 to 400       400/400
(100 %)
2 diff
(99.5 %id)
BU731997 eye, RPE and Choroid .d 1236 to 1833 619 to 19   fully sequenced, AAA   601/601
(100 %)
3 diff
(99.6 %id)
BM666002 eye, fetal eyes .d 1257 to 1833 595 to 19   AAA   577/578
(99 %)
0 diff
(100 %id)
AW245424 lung, small cell carcinoma .d 1293 to 1833 551 to 11   AAA   541/541
(100 %)
1 diff
(99.9 %id)
AW410735 muscle, rhabdomyosarcoma .d 1330 to 1833 542 to 38   AAA   505/505
(100 %)
1 diff
(99.9 %id)
BU738308 eye, lens .d 1362 to 1833 490 to 19   AAA   472/472
(100 %)
2 diff
(99.6 %id)
BX324509 Neuroblastoma Cot 25-normalized .d 1404 to 1812 412 to 1   fully sequenced,   412/412
(100 %)
0 diff
(100 %id)
N31601 melanocyte .d 1420 to 1833 414 to 1       414/414
(100 %)
3 diff
(99.3 %id)
DC427326 ovary, tumor tissue .d 1451 to 1833 383 to 1       383/383
(100 %)
2 diff
(99.5 %id)
BU735660 eye, fetal eyes .d 1586 to 1833 266 to 19   AAA   248/248
(100 %)
0 diff
(100 %id)
DB035072 testis .e 1 to 326 3 to 328   capped   327/327
(100 %)
2 diff
(99.4 %id)
DA072750 cerebellum .e 1 to 249 2 to 250   tiling clone, capped   249/249
(100 %)
0 diff
(100 %id)
DA691650   .e 1 to 249 2 to 250   capped   249/249
(100 %)
0 diff
(100 %id)
CN364397 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 18 to 319 1 to 302       302/302
(100 %)
3 diff
(99.1 %id)
AL521451 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 62 to 893 1 to 830   fully sequenced,   830/830
(100 %)
8 diff
(99.1 %id)
BM847349 lymph node, stomach .e 69 to 252 1 to 184       184/184
(100 %)
0 diff
(100 %id)
AU104828   .e 75 to 124 1 to 50       50/50
(100 %)
2 diff
(96.0 %id)
AK226085 brain .e 94 to 1791 1 to 1701 G215S S223G G224S S228G G229S ... tiling clone,   1701/1701
(100 %)
2 diff
(99.9 %id)
AW249196 lung, small cell carcinoma .e 104 to 252 1 to 150       150/174
(86 %)
16 diff
(90.9 %id)
BX446988 neuroblastoma .e 113 to 1125 1 to 1002       1002/1013
(98 %)
23 diff
(97.8 %id)
BG747039 adenocarcinoma cell line, colon .e 125 to 907 1 to 785       785/785
(100 %)
4 diff
(99.5 %id)
BE294784 muscle, rhabdomyosarcoma .e 249 to 943 1 to 696       696/704
(98 %)
7 diff
(99.1 %id)
AU104821   .e 252 to 301 1 to 50       50/50
(100 %)
0 diff
(100 %id)
AU104822   .e 252 to 301 1 to 50       50/50
(100 %)
0 diff
(100 %id)
AU104823   .e 252 to 301 1 to 50       50/50
(100 %)
0 diff
(100 %id)
AU104826   .e 252 to 301 1 to 50       50/50
(100 %)
0 diff
(100 %id)
AU104820   .e 254 to 303 1 to 50       50/50
(100 %)
0 diff
(100 %id)
TI_57232720   .e 256 to 911 20 to 687       668/687
(97 %)
18 diff
(97.4 %id)
BG768589 melanotic melanoma, high MDR (cell line), skin .e 258 to 1068 1 to 827       827/955
(86 %)
17 diff
(98.3 %id)
TI_57182909   .e 260 to 1058 32 to 825       794/825
(96 %)
12 diff
(98.6 %id)
TI_57232215   .e 260 to 1037 27 to 805       779/809
(96 %)
8 diff
(99.1 %id)
TI_57181723   .e 262 to 1060 27 to 827       801/933
(85 %)
19 diff
(98.0 %id)
TI_57164948   .e 262 to 1039 23 to 803       781/804
(97 %)
15 diff
(98.2 %id)
CR617105 Placenta Cot 25-normalized .e 264 to 1764 1 to 1501 exact tiling clone,   1501/1501
(100 %)
0 diff
(100 %id)
BX339703 Placenta Cot 25-normalized .e 264 to 1091 1 to 827   fully sequenced,   827/827
(100 %)
3 diff
(99.7 %id)
BX443906 fetal liver, Liver .e 264 to 1267 1 to 998       998/1060
(94 %)
20 diff
(98.2 %id)
BI765422 pooled colon, kidney, stomach .e 264 to 328 1 to 65       65/65
(100 %)
0 diff
(100 %id)
BI771053 pooled lung and spleen .e 264 to 1058 1 to 790       790/790
(100 %)
6 diff
(99.3 %id)
TI_57243257   .e 264 to 1058 41 to 835       795/836
(95 %)
12 diff
(98.6 %id)
CR599587 Placenta Cot 25-normalized .e 265 to 1759 1 to 1495 exact     1495/1495
(100 %)
0 diff
(100 %id)
BX336882 Placenta Cot 25-normalized .e 265 to 1003 1 to 738   fully sequenced,   738/738
(100 %)
1 diff
(99.9 %id)
AL531911 brain, fetal liver, Liver, neuroblastoma cells .e 265 to 1177 1 to 908       908/1014
(89 %)
13 diff
(98.8 %id)
BG120454 adenocarcinoma, cell line, Liver .e 265 to 939 1 to 678       679/678
(100 %)
9 diff
(98.7 %id)
BI906321 leukocyte .e 265 to 1037 1 to 774       774/778
(99 %)
2 diff
(99.8 %id)
BM916523 amelanotic melanoma, cell line, skin .e 266 to 959 1 to 700       700/1169
(59 %)
17 diff
(98.6 %id)
BX464208 fetal liver, Liver .e 267 to 1230 1 to 959       959/1050
(91 %)
17 diff
(98.4 %id)
BI768905 pooled lung and spleen .e 267 to 1060 1 to 795       795/901
(88 %)
13 diff
(98.6 %id)
BI836107 pooled pancreas and spleen .e 267 to 1039 1 to 775       775/776
(99 %)
13 diff
(98.4 %id)
BM011061 brain, neuroblastoma, cell line .e 267 to 1117 1 to 850       850/850
(100 %)
21 diff
(97.6 %id)
NM_007367.2   .e 267 to 1791 1 to 1525 exact RefSeq, AAA   1525/1525
(100 %)
0 diff
(100 %id)
BU849622 ovary, teratocarcinoma, cell line .e 268 to 1151 1 to 884       884/896
(98 %)
13 diff
(98.6 %id)
TI_59379954   .e 268 to 1117 138 to 986       849/849
(100 %)
20 diff
(97.7 %id)
BI918125 brain .e 269 to 1058 1 to 790       790/791
(99 %)
6 diff
(99.3 %id)
BI753547 brain .e 302 to 1135 1 to 834       834/834
(100 %)
4 diff
(99.6 %id)
TI_57219777   .e 302 to 1135 37 to 870       834/870
(95 %)
10 diff
(98.9 %id)
CN364405 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 303 to 918 1 to 617       617/617
(100 %)
3 diff
(99.6 %id)
DA541760 lung .e 387 to 984 2 to 599   capped   598/598
(100 %)
1 diff
(99.9 %id)
L38696   .e 389 to 1791 1 to 1406 E198D Q199E G215S S223G G224S ... AAA   1406/1406
(100 %)
5 diff
(99.7 %id)
CD246267 embryonic stem cells, WA01, passage 38 .e 400 to 1129 23 to 752       730/856
(85 %)
11 diff
(98.8 %id)
AK291054   .e 422 to 1791 1 to 1373 R141C G215S S223G G224S S228G ...     1373/1373
(100 %)
3 diff
(99.8 %id)
DA726102   .e 423 to 980 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BQ069791 brain, neuroblastoma, cell line .e 424 to 1238 1 to 818       818/1012
(80 %)
9 diff
(99.2 %id)
BG577297 breast, mammary adenocarcinoma, cell line .e 466 to 1194 1 to 728       728/728
(100 %)
4 diff
(99.5 %id)
TI_45235921   .e 472 to 1131 64 to 723   fully sequenced, AAA   660/723
(91 %)
7 diff
(99.1 %id)
BE410804 choriocarcinoma, placenta .e 473 to 1065 34 to 627       594/841
(70 %)
13 diff
(98.5 %id)
CN364408 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 475 to 1197 9 to 731       723/731
(98 %)
7 diff
(99.1 %id)
AW250514 lung, small cell carcinoma .e 495 to 1040 10 to 555       546/555
(98 %)
6 diff
(99.0 %id)
BE872207 adenocarcinoma, colon .e 499 to 1160 1 to 668       668/668
(100 %)
8 diff
(98.9 %id)
BF346931 anaplastic oligodendroglioma with 1p/19qloss, brain .e 501 to 1241 1 to 743       743/744
(99 %)
10 diff
(98.7 %id)
BE871118 adenocarcinoma, colon .e 507 to 1265 1 to 755       755/891
(84 %)
15 diff
(98.4 %id)
BE812105 amnion_normal .e 560 to 933 373 to 1       373/373
(100 %)
5 diff
(98.7 %id)
BF975129 B-cells, primary B-cells from tonsils (cell line) .e 609 to 1385 1 to 770       770/980
(78 %)
15 diff
(98.5 %id)
CR990865 T-Lymphocytes .e 610 to 1241 1 to 641       641/641
(100 %)
11 diff
(98.3 %id)
BM740631 Ascites, stomach .e 613 to 1119 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
CN364415 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 615 to 1246 9 to 640       632/640
(98 %)
11 diff
(98.3 %id)
BI858620 breast, mammary adenocarcinoma, cell line .e 628 to 1325 1 to 700       700/700
(100 %)
2 diff
(99.8 %id)
TI_57191546   .e 628 to 1325 76 to 775       700/700
(100 %)
2 diff
(99.8 %id)
BE245957 leukopheresis .e 632 to 1137 1 to 506       506/506
(100 %)
3 diff
(99.5 %id)
BF909462 uterus_tumor .e 706 to 1167 468 to 7     Submitted on the opposite strand 462/468
(98 %)
0 diff
(100 %id)
BE736150 adenocarcinoma, Pancreas .e 708 to 1393 1 to 685       685/934
(73 %)
13 diff
(98.7 %id)
AL531910 brain, fetal liver, Liver, neuroblastoma cells .e 725 to 1741 1018 to 4       1015/1026
(98 %)
39 diff
(96.2 %id)
BG028042 Bone, osteosarcoma, cell line .e 846 to 1569 1 to 727       727/1093
(66 %)
29 diff
(97.4 %id)
BG256264 adenocarcinoma, cell line, Prostate .e 846 to 1604 1 to 748       748/951
(78 %)
17 diff
(98.3 %id)
BF026152 melanotic melanoma, skin .e 847 to 1617 1 to 763       763/763
(100 %)
24 diff
(96.9 %id)
BX399790 Placenta Cot 25-normalized .e 860 to 1720 862 to 1       862/862
(100 %)
13 diff
(98.5 %id)
BM796109 Ascites, stomach .e 871 to 1172 1 to 301       301/301
(100 %)
2 diff
(99.4 %id)
AL521450 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .e 878 to 1761 888 to 1   fully sequenced,   888/888
(100 %)
2 diff
(99.8 %id)
BX336881 Placenta Cot 25-normalized .e 973 to 1759 790 to 1   fully sequenced,   790/790
(100 %)
6 diff
(99.3 %id)
BX339702 Placenta Cot 25-normalized .e 1030 to 1764 740 to 3   fully sequenced,   738/740
(99 %)
4 diff
(99.5 %id)
TI_45235922   .e 1101 to 1716 641 to 6   fully sequenced,   612/617
(99 %)
26 diff
(95.8 %id)
DB337361 testis .e 1273 to 1791 520 to 1       520/520
(100 %)
1 diff
(99.9 %id)
BM008828 adenocarcinoma, Pancreas .e 1385 to 1791 1 to 407   AAA   407/407
(100 %)
5 diff
(98.8 %id)
TI_59386545   .e 1386 to 1791 114 to 519   AAA   406/406
(100 %)
4 diff
(99.1 %id)
BE736482 adenocarcinoma, Pancreas .e 1405 to 1791 1 to 387       387/387
(100 %)
0 diff
(100 %id)
DB509309 testis .e 1407 to 1791 1 to 385     Submitted on the opposite strand 385/385
(100 %)
4 diff
(99.0 %id)
AA295946 thymus .e 1409 to 1683 1 to 276       276/276
(100 %)
3 diff
(99.0 %id)
BM686952 eye, optic nerve .e 1410 to 1791 1 to 382   AAA   382/382
(100 %)
0 diff
(100 %id)
BE858640 brain, glioblastoma (pooled) .e 1431 to 1791 361 to 1       361/361
(100 %)
0 diff
(100 %id)
AI138296   .e 1434 to 1791 368 to 11   AAA   358/358
(100 %)
0 diff
(100 %id)
AI265787 borderline ovarian carcinoma, ovary .e 1474 to 1584 111 to 1       111/111
(100 %)
0 diff
(100 %id)
AI499021 anaplastic oligodendroglioma, brain .e 1475 to 1791 317 to 1       317/317
(100 %)
0 diff
(100 %id)
BF058901 fibrotheoma, ovary .e 1485 to 1791 307 to 1       307/307
(100 %)
0 diff
(100 %id)
BQ953884 epidermoid carcinoma, cell line, lung .e 1600 to 2441 1 to 844   tiling clone,   844/948
(89 %)
9 diff
(99.1 %id)
CR620280 B cells (Ramos cell line) Cot 25-normalized .f 1 to 1544 4 to 1547 exact tiling clone,   1547/1547
(100 %)
0 diff
(100 %id)
AW403634 lymph .f 3 to 540 1 to 538       538/538
(100 %)
3 diff
(99.5 %id)
BU740278 eye, lens .f 801 to 1571 792 to 19   AAA   774/774
(100 %)
6 diff
(99.3 %id)
BQ575974 Chondrosarcoma Grade II, Left Pelvis .f 808 to 1571 787 to 19   AAA   769/769
(100 %)
11 diff
(98.6 %id)
AW574789 lymph .f 1104 to 1571 485 to 18   tiling clone, AAA   468/468
(100 %)
0 diff
(100 %id)
BQ277726 ovary, teratocarcinoma, cell line .g 1 to 814 1 to 820 D160G G161W G162K G163W A164R ... tiling clone,   820/1050
(78 %)
9 diff
(99.2 %id)
BG469312 adenocarcinoma cell line, colon .h 1 to 799 1 to 807 K102N R103E A104S A105S S106I ... tiling clone,   807/813
(99 %)
18 diff
(97.8 %id)
BE746010 adenocarcinoma cell line, ovary .i 1 to 870 1 to 874 A126R V127S P128L V129* tiling clone,   874/1019
(85 %)
43 diff
(95.8 %id)
AK299766 brain .j 1 to 859 1 to 859 exact tiling clone,   859/859
(100 %)
1 diff
(99.9 %id)
BF876767 lung_tumor .k 1 to 304 9 to 311   tiling clone,   303/319
(94 %)
7 diff
(97.9 %id)
BF877294 lung_tumor .k 1 to 304 9 to 311       303/319
(94 %)
7 diff
(97.9 %id)
BF794107 lymph, lymphoma, cell line .k 173 to 929 1 to 754 G51S S59G G60S S64G G65S ...     752/975
(77 %)
31 diff
(96.9 %id)
TI_57180621   .k 173 to 1007 73 to 909 G51S S59G G60S S64G G65S ...     837/909
(92 %)
16 diff
(98.3 %id)
BQ924528 epidermoid carcinoma, cell line, lung .k 180 to 1082 940 to 20 L2Q K3D S5V E6K L7E ... AAA Submitted on the opposite strand 921/931
(98 %)
52 diff
(94.5 %id)
BM691291 eye, RPE and Choroid .k 181 to 714 11 to 548   fully sequenced,   538/548
(98 %)
9 diff
(98.4 %id)
TI_149287017   .k 187 to 1082 952 to 66 A9X A37X A50X G51S S59G ... AAA   887/1123
(78 %)
21 diff
(98.2 %id)
BE275888 melanotic melanoma, skin .k 198 to 871 1 to 671 G51S S59G G60S S64G G65S ...     671/740
(90 %)
19 diff
(97.5 %id)
TI_149304759   .k 200 to 1082 954 to 76 L2X S19P L24X N38X A50P ... AAA   879/982
(89 %)
22 diff
(97.8 %id)
TI_154127073   .k 223 to 1082 947 to 94 K11X L28X A37P N38I P39Q ... AAA   855/959
(89 %)
31 diff
(96.8 %id)
TI_149308831   .k 240 to 1082 930 to 91 L28X A37X G51S S59G G60S ... AAA   840/981
(85 %)
14 diff
(98.6 %id)
AI040012 senescent fibroblast .k 248 to 1084 840 to 6 L2V A9S T12A L25X L28W ...     835/852
(98 %)
29 diff
(96.6 %id)
AY635580   .k 257 to 988 1 to 737 L25X S26C G51S S59G G60S ...     737/739
(99 %)
11 diff
(98.6 %id)
BG030172 breast, mammary adenocarcinoma, cell line .k 261 to 988 1 to 722 E92K A93H R94G T95P R96E ... tiling clone,   722/729
(99 %)
12 diff
(98.4 %id)
AI762499 B-cell, chronic lymphotic leukemia .k 263 to 1083 822 to 1 A9S L24X R27S G51S G52X ...     822/822
(100 %)
17 diff
(98.0 %id)
BG824357 adenocarcinoma cell line, colon .k 278 to 1084 1 to 808 G51S S59G G60S S64G G65S ...     808/978
(82 %)
33 diff
(96.7 %id)
BM747393 Ascites, stomach .k 287 to 824 1 to 539 G51S S59G G60S S64G G65S ...     539/539
(100 %)
3 diff
(99.5 %id)
BE560644 Burkitt lymphoma, lymph .k 300 to 1051 1 to 740 E92K A93H R94G T95P R96E ... AAA   740/764
(96 %)
37 diff
(95.2 %id)
BE378387 endometrium, adenocarcinoma cell line, uterus .k 328 to 991 1 to 663 G51S S59G G60S S64G G65S ...     663/673
(98 %)
11 diff
(98.4 %id)
BM710076 eye, optic nerve .k 340 to 528 1 to 189   fully sequenced,   189/189
(100 %)
0 diff
(100 %id)
TI_149288084   .k 349 to 1093 817 to 83   AAA   735/949
(77 %)
13 diff
(98.7 %id)
CR626560 B cells (Ramos cell line) .k 352 to 1084 1 to 733       733/733
(100 %)
0 diff
(100 %id)
BX421095 B cells (Ramos cell line) .k 352 to 1084 1 to 731   fully sequenced,   731/731
(100 %)
3 diff
(99.6 %id)
BQ648429 hepatocellular carcinoma, cell line, Liver .k 361 to 963 81 to 689       609/1186
(51 %)
14 diff
(98.9 %id)
TI_149283885   .k 377 to 1082 783 to 77   AAA   707/708
(99 %)
6 diff
(99.2 %id)
TI_154026447   .k 377 to 1081 792 to 87   AAA   706/707
(99 %)
9 diff
(98.8 %id)
AI752651 Bone, Hip .k 379 to 820 1 to 442       442/442
(100 %)
4 diff
(99.1 %id)
BE313624 brain, neuroblastoma .k 391 to 1045 1 to 655       655/794
(82 %)
11 diff
(98.7 %id)
BU527253 epidermoid carcinoma, cell line, lung .k 393 to 1082 717 to 20   AAA Submitted on the opposite strand 698/885
(78 %)
10 diff
(98.9 %id)
BG285546 bladder, transitional cell papilloma, cell line .k 396 to 1082 1 to 690       690/730
(94 %)
15 diff
(98.0 %id)
TI_149289853   .k 398 to 1082 763 to 78   AAA   686/686
(100 %)
3 diff
(99.6 %id)
DB222157 trachea .k 400 to 918 2 to 523   capped   522/522
(100 %)
2 diff
(99.7 %id)
CD743004 Alveolar Macrophage, lung .k 425 to 1082 679 to 19   AAA   661/661
(100 %)
2 diff
(99.7 %id)
TI_1241112227   .k 431 to 846 1 to 415       415/1242
(33 %)
7 diff
(99.5 %id)
TI_159679384   .k 457 to 1093 761 to 120   AAA   642/981
(65 %)
35 diff
(96.5 %id)
BM970158 lung .k 473 to 1093 638 to 19   tiling clone, AAA   620/620
(100 %)
1 diff
(99.9 %id)
BM671237 eye, optic nerve .k 498 to 1082 605 to 19   fully sequenced, AAA   587/587
(100 %)
3 diff
(99.5 %id)
BQ574776 Chondrosarcoma Grade II, Left Pelvis .k 519 to 1082 582 to 19   AAA   564/564
(100 %)
0 diff
(100 %id)
CD628135   .k 521 to 902 392 to 12       381/396
(96 %)
0 diff
(100 %id)
TI_45236226   .k 528 to 1084 90 to 645   fully sequenced,   556/645
(86 %)
7 diff
(99.0 %id)
TI_154103571   .k 542 to 1082 628 to 87   AAA   542/784
(69 %)
11 diff
(98.6 %id)
TI_154118349   .k 563 to 1083 547 to 27   AAA   521/920
(56 %)
27 diff
(97.1 %id)
BQ945690 epidermoid carcinoma, cell line, lung .k 568 to 1082 535 to 20   AAA Submitted on the opposite strand 516/948
(54 %)
3 diff
(99.7 %id)
CD624128   .k 570 to 919 365 to 17       349/365
(95 %)
0 diff
(100 %id)
BQ675224 epidermoid carcinoma, cell line, salivary gland .k 570 to 1082 542 to 31   AAA Submitted on the opposite strand 512/516
(99 %)
5 diff
(99.1 %id)
BQ937421 epidermoid carcinoma, cell line, lung .k 571 to 1082 533 to 20   AAA Submitted on the opposite strand 514/963
(53 %)
1 diff
(99.9 %id)
BM984273 lung .k 575 to 1082 525 to 19   AAA   507/507
(100 %)
2 diff
(99.7 %id)
BQ653117 hepatocellular carcinoma, cell line, Liver .k 577 to 1082 538 to 33   AAA Submitted on the opposite strand 506/1017
(49 %)
8 diff
(99.3 %id)
BQ945578 epidermoid carcinoma, cell line, lung .k 577 to 1082 524 to 20   AAA Submitted on the opposite strand 505/510
(99 %)
2 diff
(99.7 %id)
BU528298 epidermoid carcinoma, cell line, lung .k 577 to 1082 529 to 20   AAA Submitted on the opposite strand 510/1016
(50 %)
20 diff
(98.1 %id)
TI_159693730   .k 578 to 1082 574 to 73   AAA   502/956
(52 %)
2 diff
(99.8 %id)
BM971364 lung .k 581 to 1082 522 to 19   AAA   504/504
(100 %)
4 diff
(99.3 %id)
AA847481 colon, colon tumor .k 582 to 1082 501 to 1       501/501
(100 %)
0 diff
(100 %id)
CD366081 Alveolar Macrophage, lung .k 585 to 1082 516 to 19   AAA   498/498
(100 %)
0 diff
(100 %id)
BM755775 stomach .k 589 to 891 1 to 304       304/304
(100 %)
6 diff
(98.1 %id)
BU738054 eye, lens .k 595 to 1082 506 to 19   AAA   488/488
(100 %)
0 diff
(100 %id)
AI075059 breast .k 597 to 1082 486 to 1       486/486
(100 %)
0 diff
(100 %id)
DB572727 hypothalamus .k 598 to 1082 1 to 485     Submitted on the opposite strand 485/485
(100 %)
4 diff
(99.2 %id)
BP392989 pancreatic islet .k 599 to 1082 1 to 484     Submitted on the opposite strand 484/484
(100 %)
0 diff
(100 %id)
DB522181 testis .k 600 to 1082 1 to 483     Submitted on the opposite strand 483/483
(100 %)
0 diff
(100 %id)
DB567607 hypothalamus .k 605 to 1082 1 to 478     Submitted on the opposite strand 478/478
(100 %)
0 diff
(100 %id)
DB524828 testis .k 606 to 1082 1 to 478     Submitted on the opposite strand 478/478
(100 %)
1 diff
(99.8 %id)
DB573484 hypothalamus .k 609 to 1082 1 to 473     Submitted on the opposite strand 473/473
(100 %)
1 diff
(99.8 %id)
DB574990 hypothalamus .k 610 to 1082 1 to 473     Submitted on the opposite strand 473/473
(100 %)
1 diff
(99.8 %id)
AI339906 adenocarcinoma, colon .k 612 to 1082 471 to 1       471/471
(100 %)
0 diff
(100 %id)
AA811833 germinal center B cell .k 615 to 875 261 to 1       261/261
(100 %)
2 diff
(99.3 %id)
AW390086 stomach .k 618 to 1009 399 to 4       396/399
(99 %)
6 diff
(98.5 %id)
AA748472 germinal center B cell .k 618 to 875 259 to 1       259/259
(100 %)
5 diff
(98.1 %id)
AA835998 germinal center B cell .k 618 to 875 259 to 1       259/259
(100 %)
7 diff
(97.3 %id)
AW368346 head_neck .k 619 to 998 380 to 1       380/380
(100 %)
3 diff
(99.3 %id)
AW368347 head_neck .k 619 to 1003 389 to 1       389/389
(100 %)
9 diff
(97.7 %id)
AW368349 head_neck .k 619 to 1015 396 to 1       396/396
(100 %)
9 diff
(97.8 %id)
AW368361 head_neck .k 619 to 1054 441 to 10       432/441
(97 %)
1 diff
(99.8 %id)
BF349662 head_neck .k 619 to 970 355 to 1       355/355
(100 %)
8 diff
(97.8 %id)
CR623593 Placenta Cot 25-normalized .k 619 to 1084 1 to 466       466/466
(100 %)
0 diff
(100 %id)
F33778 pectoral muscle (after mastectomy) .k 620 to 1005 1 to 384       384/384
(100 %)
3 diff
(99.3 %id)
AW007567 colon .k 624 to 1083 460 to 1       460/460
(100 %)
0 diff
(100 %id)
BF877038 lung_tumor .k 625 to 815 196 to 6     Submitted on the opposite strand 191/196
(97 %)
1 diff
(99.5 %id)
TI_154126751   .k 627 to 1082 534 to 78   AAA   457/985
(46 %)
3 diff
(99.7 %id)
DB520500 testis .k 629 to 1082 1 to 454     Submitted on the opposite strand 454/454
(100 %)
2 diff
(99.6 %id)
BM052976 Islets of Langerhans, Pancreas .k 634 to 876 1 to 243       243/243
(100 %)
0 diff
(100 %id)
AA496516 ovarian tumor, ovary .k 646 to 1055 1 to 408   fully sequenced,   408/408
(100 %)
2 diff
(99.6 %id)
AI935947 normal prostate, Prostate .k 650 to 1082 433 to 1       433/433
(100 %)
0 diff
(100 %id)
BU726474 eye, RPE and Choroid .k 653 to 1093 460 to 19   fully sequenced, AAA   442/442
(100 %)
4 diff
(99.1 %id)
AA316642 lung .k 655 to 975 1 to 324       324/324
(100 %)
4 diff
(98.8 %id)
AW938105 denis_drash .k 657 to 865 212 to 1     Submitted on the opposite strand 210/212
(99 %)
11 diff
(94.9 %id)
AI480255 pooled .k 660 to 1082 423 to 1       423/423
(100 %)
0 diff
(100 %id)
BM794966 Ascites, stomach .k 666 to 1083 1 to 418       418/418
(100 %)
0 diff
(100 %id)
BM673150 eye, optic nerve .k 666 to 1082 435 to 19   AAA   417/417
(100 %)
2 diff
(99.6 %id)
BE077338 breast .k 670 to 862 214 to 25     Submitted on the opposite strand 190/216
(87 %)
1 diff
(99.6 %id)
BX455735 B cells (Ramos cell line) .k 693 to 1081 391 to 1   fully sequenced,   391/391
(100 %)
3 diff
(99.3 %id)
TI_45236227   .k 693 to 1035 342 to 2   fully sequenced,   341/342
(99 %)
0 diff
(100 %id)
AA496450 ovarian tumor, ovary .k 884 to 1083 200 to 1   fully sequenced,   200/200
(100 %)
0 diff
(100 %id)
AA885763 pooled germ cell tumors .l 1 to 319 319 to 1   tiling clone,   319/319
(100 %)
0 diff
(100 %id)
AI243809 pooled .l 18 to 332 315 to 1   tiling clone,   315/315
(100 %)
0 diff
(100 %id)
AL042396 testis .m 1 to 683 1 to 689   tiling clone,   689/689
(100 %)
7 diff
(99.0 %id)
DA097674 cerebellum .m 528 to 1076 2 to 550   tiling clone, capped   549/549
(100 %)
3 diff
(99.5 %id)
BI051053 placenta_normal .m 617 to 977 361 to 1       361/362
(99 %)
3 diff
(99.2 %id)
TI_151755704   .m 653 to 1292 686 to 47   tiling clone,   640/940
(68 %)
0 diff
(100 %id)
BM724357 eye, fetal eye .m 655 to 1288 1 to 634       634/635
(99 %)
2 diff
(99.7 %id)
DA443507 tongue, tumor tissue .m 668 to 1265 2 to 599   capped   598/598
(100 %)
1 diff
(99.9 %id)
DA522078 brain .m 882 to 1448 2 to 568   tiling clone, to resequence, capped   567/567
(100 %)
0 diff
(100 %id)
R54909 breast .m 1193 to 1467 1 to 279       279/457
(61 %)
5 diff
(99.0 %id)
CN281748 embryonic stem cells, cell lines H1, H7, andH9 .m 1417 to 1786 22 to 391   tiling clone,   370/391
(94 %)
6 diff
(98.5 %id)
DA375088 thalamus .m 1511 to 2060 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA537078 heart .m 1553 to 2121 2 to 570   tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
DA953796 Spleen .m 1997 to 2553 2 to 559   tiling clone, capped   558/558
(100 %)
1 diff
(99.9 %id)
DB317276 brain .m 3264 to 3785 522 to 1 Q41X E83X tiling clone, to resequence,   522/522
(100 %)
2 diff
(99.7 %id)
H46063 brain .n 1 to 316 1 to 315 A4X V5S P6L V7* tiling clone,   315/316
(99 %)
3 diff
(99.1 %id)
DA409208 thalamus .o 1 to 558 2 to 559 exact tiling clone, capped   558/558
(100 %)
0 diff
(100 %id)
BQ028450 mixed .p-u 1 to 525 543 to 19 exact tiling clone, AAA   525/538
(97 %)
1 diff
(99.9 %id)
AW130749 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .p-u 50 to 459 411 to 1 exact     411/411
(100 %)
3 diff
(99.3 %id)
AI299919 carcinoid, lung .p-u 114 to 524 411 to 1 G32V     411/411
(100 %)
1 diff
(99.8 %id)
W86566 liver and spleen .p-u 150 to 523 1 to 380   fully sequenced,   380/380
(100 %)
9 diff
(97.7 %id)
BI019610 marrow .p-u 212 to 397 186 to 1       186/204
(91 %)
0 diff
(100 %id)
W86680 liver and spleen .p-u 260 to 525 268 to 1   fully sequenced,   268/268
(100 %)
0 diff
(100 %id)
CD369471 Alveolar Macrophage, lung .q 1 to 500 521 to 19 exact tiling clone, AAA   503/503
(100 %)
3 diff
(99.5 %id)
DB444463 testis .r 1 to 420 1 to 421 R18K tiling clone,   421/433
(97 %)
5 diff
(98.9 %id)
AI085913 senescent fibroblast .s 1 to 416 420 to 5 exact tiling clone,   416/420
(99 %)
0 diff
(100 %id)
BE904167 epithelioid carcinoma, Pancreas .s 119 to 410 1 to 292 exact     292/292
(100 %)
0 diff
(100 %id)
AA931789 carcinoid, lung .s 151 to 414 264 to 1       264/264
(100 %)
0 diff
(100 %id)
AI249333 adenocarcinoma, Pancreas .s 151 to 415 265 to 1       265/265
(100 %)
0 diff
(100 %id)
AI424213 brain, glioblastoma (pooled) .s 167 to 414 248 to 1       248/248
(100 %)
0 diff
(100 %id)
AA496511 ovarian tumor, ovary .s 172 to 414 1 to 243   fully sequenced, AAA   243/243
(100 %)
0 diff
(100 %id)
BM541976 melanotic melanoma, skin .s 176 to 414 1 to 239   AAA   239/239
(100 %)
0 diff
(100 %id)
BM052864 Islets of Langerhans, Pancreas .s 182 to 414 1 to 233   AAA   233/233
(100 %)
0 diff
(100 %id)
BG056479 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .s 208 to 416 209 to 1       209/209
(100 %)
0 diff
(100 %id)
AA807900 normal prostate, Prostate .s 229 to 414 216 to 31   AAA   186/186
(100 %)
0 diff
(100 %id)
AA496627 ovarian tumor, ovary .s 294 to 414 121 to 1   fully sequenced,   121/121
(100 %)
0 diff
(100 %id)
AL045134 testis .s 295 to 414 151 to 32   AAA   120/120
(100 %)
0 diff
(100 %id)
CB266680 adipose .t 1 to 414 1 to 414 exact tiling clone,   414/414
(100 %)
0 diff
(100 %id)
CN364419 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .u 1 to 378 1 to 378 exact tiling clone,   378/378
(100 %)
1 diff
(99.8 %id)
BF377799 testis_normal .va-u 1 to 373 1 to 373 K3* tiling clone,   373/373
(100 %)
3 diff
(99.2 %id)
AI340581 bone marrow, stem cell 34+/38+ .vb 1 to 227 13 to 239 exact tiling clone, AAA Submitted on the opposite strand 227/239
(94 %)
6 diff
(97.5 %id)
TI_154132182   Gene RALY, variant not shown         This clone was ignored    
91 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q, .r, .s, .t, .u, .va-u, .vb Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI